• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

a year ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Jabil Inc Reports Strong Q1 Financial Results for Fiscal Year 2026

chest

Jabil Inc has exceeded earnings per share and revenue expectations for Q1 2026, reporting a core diluted EPS of 285 and net revenue of 83 billion.

user avatarRajesh Kumar

Jabil Inc Raises Fiscal Year 2026 Revenue Guidance

chest

Jabil Inc has raised its revenue guidance for fiscal year 2026, projecting a net revenue range of 324 billion, with expectations for the second quarter between 75 billion and 80 billion.

user avatarJesper Sørensen

Everything to Enhance DeFi Experience with Geneve Upgrade in Summer 2026

chest

Everything is set to introduce innovative features in the upcoming Geneve upgrade, planned for summer 2026.

user avatarLucas Weissmann

SEC Approves DTCC's Tokenization Service with No-Action Letter

chest

The SEC has issued a no-action letter to DTCC, allowing it to proceed with a securities tokenization service on preapproved blockchains.

user avatarFilippo Romano

DTCC Announces Plans for Tokenized US Treasurys on Blockchain

chest

DTCC plans to bring tokenized US Treasury securities onchain using the Canton Network, aiming for a minimum viable product by 2026.

user avatarTomas Novak

RWA Project Plume Gains Favor with Trump Administration

chest

The cofounders of the RWA project Plume, Chris Yin and Teddy Pornprinya, recently met with senior officials from the Trump administration, resulting in a surprisingly positive reaction and highlighting the potential of real-world asset tokenization.

user avatarEmily Carter

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.